Defective TALDO1 does not transform Fru(6)P, E4P to SH7P, GA3P

Stable Identifier
R-HSA-5659998
Type
Reaction [transition]
Species
Homo sapiens
Compartment
cytosol
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective TALDO1 does not transform Fru(6)P, E4P to SH7P, GA3P
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Defective TALDO1 (transaldolase 1) fails to transform fructose 6-phosphate (Fru(6)P) and erythrose 4-phosphate (E4P) to sedoheptulose 7-phosphate (SH7P) and glyceraldehyde 3-phosphate (GA3P). This defect has been associated with congenital liver disease and an array of other symptoms. The deficiency was first described by Verhoeven and colleagues (2001). Both the range and severity of these abnormalities are variable from patient to patient (Wamelink et al. 2008a; Eyaid et al. 2013). The three missense mutant alleles annotated here are associated with absence of detectable transaldolase activity in tissues from homozygous affected individuals (LeDuc et al. 2014; Verhoeven et al. 2005; Wamelink et al. 2008b).
Literature References
PubMed ID Title Journal Year
11283793 Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.

Verhoeven, NM, Huck, JHJ, Roos, B, Struys, EA, Salomons, GS, Douwes, AC, van der Knaap, MS, Jakobs, C

Am J Hum Genet 2001
24097415 Novel association of early onset hepatocellular carcinoma with transaldolase deficiency

Leduc, CA, Crouch, EE, Wilson, A, Lefkowitch, J, Wamelink, MM, Jakobs, C, Salomons, GS, Sun, X, Shen, Y, Chung, WK

JIMD Rep 2014
18987987 The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review

Wamelink, MM, Struys, EA, Jakobs, C

J Inherit Metab Dis 2008
18331807 Transaldolase deficiency in a two-year-old boy with cirrhosis

Wamelink, MM, Struys, EA, Salomons, GS, Fowler, D, Jakobs, C, Clayton, PT

Mol. Genet. Metab. 2008
23315216 Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype

Eyaid, W, Al Harbi, T, Anazi, S, Wamelink, MM, Jakobs, C, Al Salammah, M, Al Balwi, M, Alfadhel, M, Alkuraya, FS

J. Inherit. Metab. Dis. 2013
15877206 A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency

Verhoeven, NM, Wallot, M, Huck, JHJ, Dirsch, O, Ballauf, A, Neudorf, U, Salomons, GS, van der Knaap, MS, Voit, T, Jakobs, C

J. Inherit. Metab. Dis. 2005
Participants
Input
Participates
as an event of
Catalyst Activity

transaldolase activity of TALDO1 mutant dimers [cytosol]

Physical Entity
TALDO1 mutant dimers [cytosol] (Homo sapiens)
Activity
transaldolase activity (GO:0004801)
Normal reaction
D-fructose 6-phosphate + D-erythrose 4-phosphate <=> sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate (Homo sapiens)
Functional status

Loss of function of TALDO1 mutant dimers [cytosol]

Normal Entity
Disease Entity
Status
Disease
Name Identifier Synonyms
carbohydrate metabolic disorder DOID:2978 disorder of carbohydrate transport and metabolism, inborn errors of carbohydrate metabolism, inborn carbohydrate metabolism disorder
Cross References
Mondo
Authored
D'Eustachio, P  (2015-08-18)
Reviewed
Jassal, B  (2015-08-18)
Created
D'Eustachio, P  (2015-01-03)
Cite Us!